Cargando…

Evaluation of treatment adherence in patients with mental illness

INTRODUCTION: Treatment adherence, is defined as “the extent to which a person’s behavior — taking medication, following a diet, and/or executing lifestyle changes — corresponds with the agreed recommendations from a healthcare provider.” The course of patients with mental health is habitually chron...

Descripción completa

Detalles Bibliográficos
Autores principales: Jemli, H., Jomli, R., Ghabi, H., Ouali, U., Ben Amor, M., Zgueb, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568183/
http://dx.doi.org/10.1192/j.eurpsy.2022.1598
_version_ 1784809584984064000
author Jemli, H.
Jomli, R.
Ghabi, H.
Ouali, U.
Ben Amor, M.
Zgueb, Y.
author_facet Jemli, H.
Jomli, R.
Ghabi, H.
Ouali, U.
Ben Amor, M.
Zgueb, Y.
author_sort Jemli, H.
collection PubMed
description INTRODUCTION: Treatment adherence, is defined as “the extent to which a person’s behavior — taking medication, following a diet, and/or executing lifestyle changes — corresponds with the agreed recommendations from a healthcare provider.” The course of patients with mental health is habitually chronic and based on an indefinite continuation of treatment to sustain remission and prevent relapses. Treatment adherence issues are the main obstacles in the management of these patients OBJECTIVES: The aim of the present study was to evaluate treatment adherence in patients with mental health and the demogrphic and clinical factors associated with it. METHODS: It was a cross-sectional study conduced at the department of Psychiatry A at Razi Hospital.The validated arabic version of Morisky-Green test was used to assess medication adherence. The patients were considered as adherent if they answered ‘No ’ to all questions RESULTS: 60 patients were included, with a sex ratio M / F of 0.47. Patients were treated for bipolar disorder type1 in 45% of cases, schizophrenia in 28.3% of cases, schizoaffective disorder in 10% of cases and depressive disorder in 6.7% of cases. 50% of included patients had Moderate level of adherence, 35% were considered as non- adherent and only 13.3% had high adherence. The reported reasons for treatment discontinuation were insight (50%), financial problems (26.9%), side effects (15.4%) and unavailability of drugs (7.7%). The Morisky-Green test score were not correlated neither to the nature of the psychiatric disorder nor to multiple medication. CONCLUSIONS: We found a high proportion of nonadherence in patients with mental illness. DISCLOSURE: No significant relationships.
format Online
Article
Text
id pubmed-9568183
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-95681832022-10-17 Evaluation of treatment adherence in patients with mental illness Jemli, H. Jomli, R. Ghabi, H. Ouali, U. Ben Amor, M. Zgueb, Y. Eur Psychiatry Abstract INTRODUCTION: Treatment adherence, is defined as “the extent to which a person’s behavior — taking medication, following a diet, and/or executing lifestyle changes — corresponds with the agreed recommendations from a healthcare provider.” The course of patients with mental health is habitually chronic and based on an indefinite continuation of treatment to sustain remission and prevent relapses. Treatment adherence issues are the main obstacles in the management of these patients OBJECTIVES: The aim of the present study was to evaluate treatment adherence in patients with mental health and the demogrphic and clinical factors associated with it. METHODS: It was a cross-sectional study conduced at the department of Psychiatry A at Razi Hospital.The validated arabic version of Morisky-Green test was used to assess medication adherence. The patients were considered as adherent if they answered ‘No ’ to all questions RESULTS: 60 patients were included, with a sex ratio M / F of 0.47. Patients were treated for bipolar disorder type1 in 45% of cases, schizophrenia in 28.3% of cases, schizoaffective disorder in 10% of cases and depressive disorder in 6.7% of cases. 50% of included patients had Moderate level of adherence, 35% were considered as non- adherent and only 13.3% had high adherence. The reported reasons for treatment discontinuation were insight (50%), financial problems (26.9%), side effects (15.4%) and unavailability of drugs (7.7%). The Morisky-Green test score were not correlated neither to the nature of the psychiatric disorder nor to multiple medication. CONCLUSIONS: We found a high proportion of nonadherence in patients with mental illness. DISCLOSURE: No significant relationships. Cambridge University Press 2022-09-01 /pmc/articles/PMC9568183/ http://dx.doi.org/10.1192/j.eurpsy.2022.1598 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Jemli, H.
Jomli, R.
Ghabi, H.
Ouali, U.
Ben Amor, M.
Zgueb, Y.
Evaluation of treatment adherence in patients with mental illness
title Evaluation of treatment adherence in patients with mental illness
title_full Evaluation of treatment adherence in patients with mental illness
title_fullStr Evaluation of treatment adherence in patients with mental illness
title_full_unstemmed Evaluation of treatment adherence in patients with mental illness
title_short Evaluation of treatment adherence in patients with mental illness
title_sort evaluation of treatment adherence in patients with mental illness
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9568183/
http://dx.doi.org/10.1192/j.eurpsy.2022.1598
work_keys_str_mv AT jemlih evaluationoftreatmentadherenceinpatientswithmentalillness
AT jomlir evaluationoftreatmentadherenceinpatientswithmentalillness
AT ghabih evaluationoftreatmentadherenceinpatientswithmentalillness
AT oualiu evaluationoftreatmentadherenceinpatientswithmentalillness
AT benamorm evaluationoftreatmentadherenceinpatientswithmentalillness
AT zgueby evaluationoftreatmentadherenceinpatientswithmentalillness